Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.36M Sell
718,390
-664,516
-48% -$4.41M 0.01% 1231
2026
Q1
$7.16M Buy
1,382,906
+762,550
+123% +$4.77M 0.02% 787
2025
Q4
$4.53M Buy
620,356
+200,584
+48% +$1.94M 0.01% 826
2025
Q3
$4.18M Buy
+419,772
New +$4.65M 0.02% 758
2025
Q2
– Sell
-416,549
Closed -$2.67M – 2866
2025
Q1
$2.67M Buy
+416,549
New +$3.71M 0.02% 687
2024
Q4
– Sell
-13,487
Closed -$110K – 2612
2024
Q3
$110K Buy
+13,487
New +$140K ﹤0.01% 2041
2022
Q4
– Sell
-75,330
Closed -$1.21M – 2635
2022
Q3
$1.21M Buy
+75,330
New +$1.11M 0.01% 810
2022
Q2
– Sell
-131,026
Closed -$1.64M – 3119
2022
Q1
$1.64M Buy
+131,026
New +$1.84M 0.01% 727
2021
Q3
– Sell
-23,323
Closed -$468K – 3408
2021
Q2
$468K Sell
23,323
-703
-3% -$9.54K ﹤0.01% 1844
2021
Q1
$279K Buy
+24,026
New +$316K ﹤0.01% 2144

Other funds holding ENVX

HRT Financial's ENVX Position: Q2 2026 in Review

HRT Financial reduced its Enovix (ENVX) stake by 48% in Q2 2026, selling an estimated $4.41M and leaving 718,390 shares worth $4.36M. The position accounts for 0.01% of the portfolio, ranked #1231.

HRT Financial first reported a position in ENVX in Q1 2021 and has held it in 10 quarters since. The position peaked at $7.16M in Q1 2026. 300 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • HRT Financial held 718,390 shares of Enovix worth $4.36M as of Q2 2026.
  • HRT Financial sold 664,516 Enovix shares in Q2 2026, an estimated $4.41M.
  • Enovix made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1231 holding.
  • HRT Financial first reported a position in Enovix in Q1 2021 and has held it in 10 quarters since.
  • HRT Financial's Enovix position peaked at $7.16M in Q1 2026.
  • 300 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.